Furthermore, interleukin-1 receptor antagonist (IL-1ra) has been shown to block LPS-induced working memory deficits and systemically administered IL-1β is sufficient to induce similar deficits in an animal model of delirium during dementia [5]. Here, IL1B is linked to delirium.